Arovella Therapeutics appoints Dr. Nicole Van Der Weerden as CEO
MELBOURNE: Arovella Therapeutics Ltd. (ASX: ALA) has appointed Dr. Nicole Van Der Weerden as chief executive officer, effective Nov. 4, 2026, the company announced. Van Der Weerden, who joined Arovella in 2023 as chief operating officer, said she is proud…